|
Volumn 87, Issue 1, 2002, Pages 113-118
|
Transforming growth factor-β2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling
|
Author keywords
Chemotherapy chemoprotection; GI phase growth arrest; Oral supplementation; Transforming Growth Factor 2
|
Indexed keywords
LEDERTREXATE SP FORTE;
METHOTREXATE;
TRANSFORMING GROWTH FACTOR BETA2;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CHEMOTHERAPY;
CELL CYCLE G1 PHASE;
CELL DEATH;
CELL DIFFERENTIATION;
CELL POPULATION;
CELL PROLIFERATION;
CONTROLLED STUDY;
EPITHELIUM CELL;
GROWTH INHIBITION;
INTESTINE VILLUS;
INTESTINE VILLUS ATROPHY;
MILK;
MITOSIS INHIBITION;
NONHUMAN;
PRIORITY JOURNAL;
PROTECTION;
RAT;
STEM CELL;
WEIGHT REDUCTION;
ADMINISTRATION, ORAL;
ANIMALS;
ANTIMETABOLITES, ANTINEOPLASTIC;
ATROPHY;
CELL CYCLE;
CELL DEATH;
DISEASE MODELS, ANIMAL;
EPITHELIAL CELLS;
FEMALE;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINE, SMALL;
METHOTREXATE;
RATS;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA2;
WEIGHT LOSS;
|
EID: 0036648451
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bjc.6600342 Document Type: Article |
Times cited : (35)
|
References (27)
|